Yantai Fun Biopharmaceutical Industry Create International Life Science Innovation Demonstration City

Jiaodong Online August 4th (Reporter Jia Chuhang Li Gang, a trainee reporter Dong Chenxi) The biomedical industry as a strategic emerging industry with a competitive advantage in Yantai City, which is responsible for creating a demonstration city in international life science innovation. At the press conference of the "2022 Pharmaceutical Innovation and Development International Conference" held by the Yantai Municipal Government News Office on August 4, Yao Baoxin, a member of the Party Group and Deputy Director of Yantai Market Supervision and Administration Bureau, introduced the advantages and development of the current biomedical industry in our city. potential.

The scale of the industry has expanded steadily. At present, there are 100 enterprises in Yantai Biomedical Industry Chain, with sales revenue exceeding 100 million yuan, 13 companies with more than one billion yuan, 3 national specialized new giant companies, 9 gazelle enterprises, and the provincial manufacturing industry There are 4 single championships and 11 special "major new drug creation" in the country. Five companies are listed in China and foreign countries, and 6 companies have entered the top 100 in the domestic pharmaceutical industry and business fields. In 2021, the main business of biopharmaceutical companies in the city revenue exceeded 100 billion yuan.

Innovate the leader in China. There are 651 pharmaceutical approval documents in Yantai, focusing on 46 types of medicines, including innovative products such as Tianyouli, Energy, sodium heparin, and anal Thai, microspheres, translucent and interpretable drugs, liposuction technology, oral repair membrane, and membrane, and oral repair membranes,, oral repair membranes, and oral repair membranes. High -pressure oxygen compartment, biopharmaceutical CDMO and other technologies have domestic leading levels. Last year, the city's world's first new target therapy for systemic lupus erythematosus "Thai Sip", China's first self -developed ADC new biological new biosome "Vidicu Money", and the first domestic independent research and development The second -generation anti -psychiatric long -acting needle "injecting Lipbicone Micro ball (Ⅱ)" was approved to be listed. From this year, 1-2 kinds of innovative drugs will be available every year. The listed products such as Tadhecap have been continuously expanded to the clinic of adaptive diseases. Nearly 20 types of antitumor and cure slow diseases have become large varieties conditions.

The construction of industrial parks is comprehensive. The city's "1+3+X" biomedical industry spatial layout has been constructed, that is, the core areas of life science innovation in Muping District and high -tech zones are used as the leading construction park, and the development demonstration zone of the health and development of life in the west and the health integration development demonstration of life and health integration in the central region The district and southern high -end raw material drug green bearing area, simultaneously promotes the coordinated development of several characteristic parks. The planned area of ​​the Link Construction Park is 23.6 square kilometers. At present, it is concentrated in the concentration of advantageous resources to create the Yantai Blue Medicine Valley Life Island Park.

The innovation platform is constantly improving. There are 71 biomedical innovation platforms and scientific research platforms in the city at or above the provincial level, including 2 national -level innovation platforms, 1 national technology center, 3 national laboratories, 1 national cooperation base, 3 national postdoctoral workstation 3 In one, a group of national -honored R & D institutions settled in Yantai.

The integration of production talents is continuously accelerated. Yantai established the first biomedical industry talent alliance in Shandong Province, gathered 86 talents, more than 60 doctors, and 32 national experts, Pei Gang, Ding Jian, and foreign academician Ronbarby Ke and other leaders of industry leaders led innovation; the Institute of Innovation and Development of the Biomedical Industry was established, and an expert consulting committee and the "Yantai Biomedical Industry Think Tank" were set up. More than 70 academicians and related fields were hired to provide suggestions for industrial development.

- END -